Search Results - van Bragt, Tonke

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans

    Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans by Ulrichts, Peter, Guglietta, Antonio, Dreier, Torsten, van Bragt, Tonke, Hanssens, Valérie, Hofman, Erik, Vankerckhoven, Bernhardt, Verheesen, Peter, Ongenae, Nicolas, Lykhopiy, Valentina, Enriquez, F Javier, Cho, JunHaeng, Ober, Raimund J, Ward, E Sally, de Haard, Hans, Leupin, Nicolas

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Pharmacokinetics, Pharmacodynamics, and Safety of Intravenous Efgartigimod and Subcutaneous Efgartigimod PH20 in Healthy Chinese Participants

    Pharmacokinetics, Pharmacodynamics, and Safety of Intravenous Efgartigimod and Subcutaneous Efgartigimod PH20 in Healthy Chinese Participants by Jing, Shan, Zhang, Yu, Lin, Yang, Gu, Xiaowen, Liu, Jing, Guglietta, Antonio, Noukens, Jan, Van Bragt, Tonke, Wang, Lina, Chen, Jiajia, Reinhart, Harald, Pu, Xia

    Published in Drugs in R&D
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Pharmacokinetic / Pharmacodynamic (PK/PD) Simulations Guide Selection of the Dose for Administration of Efgartigimod Subcutaneously in a Phase 3 Clinical Trial in Patients with Primary Immune Thrombocytopenia

    Pharmacokinetic / Pharmacodynamic (PK/PD) Simulations Guide Selection of the Dose for Administration of Efgartigimod Subcutaneously in a Phase 3 Clinical Trial in Patients with Pri... by Ghanima, Waleed, McDonald, Vickie, Jain, Shivi, Carpenedo, Monica, Oliva, Esther N., Hultberg, Anna, Gandini, Domenica, Hofman, Erik, Van Bragt, Tonke, Parys, Wim, van Hoorick, Benjamin, Miyakawa, Yoshitaka, Broome, Catherine M.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Pharmacokinetics, Pharmacodynamics, and Safety of Intravenous Efgartigimod and Subcutaneous Efgartigimod PH20 in Healthy Chinese Participants: Efgartigimod in Healthy Chinese Participants

    Pharmacokinetics, Pharmacodynamics, and Safety of Intravenous Efgartigimod and Subcutaneous Efgartigimod PH20 in Healthy Chinese Participants: Efgartigimod in Healthy Chinese Parti... by Jing, Shan, Zhang, Yu, Lin, Yang, Gu, Xiaowen, Liu, Jing, Guglietta, Antonio, Noukens, Jan, Van Bragt, Tonke, Wang, Lina, Chen, Jiajia, Reinhart, Harald, Pu, Xia

    Published in Drugs in R&D
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans

    Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans by Ulrichts, Peter, Guglietta, Antonio, Dreier, Torsten, Bragt, Tonke van, Hanssens, Valérie, Hofman, Erik, Vankerckhoven, Bernhardt, Verheesen, Peter, Ongenae, Nicolas, Lykhopiy, Valentina, Enriquez, F Javier, Cho, JunHaeng, Ober, Raimund J, Ward, E Sally, de Haard, Hans, Leupin, Nicolas

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: